Your Waterstones card is changing, introducing...
TELL ME MORE
Safety Evaluation of Biotechnologically-derived Pharmaceuticals: Facilitating a Scientific Approach - Centre for Medicines Research Workshop (Paperback)
  • Safety Evaluation of Biotechnologically-derived Pharmaceuticals: Facilitating a Scientific Approach - Centre for Medicines Research Workshop (Paperback)
zoom

Safety Evaluation of Biotechnologically-derived Pharmaceuticals: Facilitating a Scientific Approach - Centre for Medicines Research Workshop (Paperback)

(editor), (editor)
£109.99
Paperback 200 Pages / Published: 13/10/2012
  • We can order this

Usually despatched within 3 weeks

  • This item has been added to your basket
Considerable investment has been made by both pharmaceutical and biotechnology companies in pharmaceutical products of biotechnology. However, because relatively few of these products have been marketed, lack of relevant experience means that uncertainty still surrounds the most appropriate strategy for their safety evaluation. The 13th CMR International Workshop, held in February 1997, provided the opportunity for regulatory authority and industry experts from Europe, Japan and the USA to share their experiences of designing safety evaluation programmes for specific product classes: colony stimulating factors, growth factors, hormones, interferons, interleukins, monoclonal antibodies for therapeutic use, and gene therapy products. Participants worked together to recommend those studies that should be considered for such safety evaluation, and those that may be unnecessary. These recommendations subsequently made a valuable contribution to the ICH guideline `Safety Studies for Biotechnological Products', which was finalised at ICH 4 in Brussels in July 1997. The Workshop proceedings not only describe the recommendations but also provide the reader with an appreciation of the science behind safety evaluation strategies used by experts, the influence of different regulatory systems on these strategies, and the type of data required by both toxicologists and clinicians before they have sufficient confidence to administer pharmaceutical products of biotechnology to humans.

Publisher: Springer
ISBN: 9789401060431
Number of pages: 200
Weight: 365 g
Dimensions: 240 x 160 x 12 mm
Edition: Softcover reprint of the original 1st ed. 199

You may also be interested in...

Drugs in Psychiatry
Added to basket
Aromatherapy Lexicon
Added to basket
£4.99
Paperback
The Dmso Handbook for Doctors
Added to basket
Prescribing Scenarios at a Glance
Added to basket
Pass the PSA
Added to basket
£32.99
Paperback
Psychiatric Drug Withdrawal
Added to basket
The Fragrant Mind
Added to basket
Oxford Handbook of Practical Drug Therapy
Added to basket
Aromatherapy
Added to basket
£1.99
Paperback
Psychiatric Drugs Explained
Added to basket

Reviews

Please sign in to write a review

Your review has been submitted successfully.